The role of GDF15 and its only known hindbrain-restricted receptor GFRAL has been extensively studied in the past years due to its relevance in the control of energy homeostasis and, thereby, being a potential therapeutic target in the control of metabolic diseases such as obesity27. Here, GFRAL is linked to metabolic disease.